How many institutional investors hold ARCT?

4 tracked institutional investors disclosed a position in ARCT (ARCTURUS THERAPEUTICS HOLDINGS) in their most recent 13F filing.

Who is the largest institutional holder of ARCT?

Cathie Wood, ARK Investment Management, holds the largest disclosed position in ARCT, valued at $65M.

Where does this ARCT ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ARCT — ARCTURUS THERAPEUTICS HOLDINGS

Name: ARCTURUS THERAPEUTICS HOLDINGS (ARCT) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ARCT?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net distribution · 2 buying vs 2 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their ARCT position last quarter, 2 bought and 2 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence

+2 tracked investors added or increased positions last quarter (Cathie Wood, Steve Cohen)
+4 tracked investors reported holding ARCT at their latest filing
+Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About ARCTURUS THERAPEUTICS HOLDINGS (ARCT)

ARCTURUS THERAPEUTICS HOLDINGS (ARCT) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $65M. Across recent filings, tracked investors recorded 7 new positions, 12 increased, 9 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ARCT

/100

Mixed Activity

Added / Increased19

Reduced9

Exited5

BearishBullish

Crowded Trade Score™

How many top investors track ARCT

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

ARCT Ownership Composition

How ARCTURUS THERAPEUTICS HOLDINGS is held across tracked investor types, based on reported 13F positions.

Dominant Type

Growth & Innovation

83% of tracked value

Institutions

tracked investors

Total Reported

$23.6M

combined 13F value

Growth & Innovation82.6%
Multi-Strategy / Quant17.4%

Growth & Innovation(1)

82.6%

Multi-Strategy / Quant(3)

17.4%

Tracked investors currently reporting ARCT

Investor	Firm	Shares	Market value	% of portfolio	As of
Cathie Wood	ARK Investment Management	2.9M	$19.5M	0.13%	Jun 30, 2026
Izzy Englander	Millennium Management	337K	$2.3M	0.00%	Jun 30, 2026
Steve Cohen	Point72 Asset Management	231.6K	$1.6M	0.00%	Jun 30, 2026
Ken Griffin	Citadel Advisors	40.9K	$275.2K	0.00%	Jun 30, 2026

Cathie WoodJun 30, 2026
ARK Investment Management
Shares
2.9M
Value
$19.5M
% Portfolio
0.13%
Izzy EnglanderJun 30, 2026
Millennium Management
Shares
337K
Value
$2.3M
% Portfolio
0.00%
Steve CohenJun 30, 2026
Point72 Asset Management
Shares
231.6K
Value
$1.6M
% Portfolio
0.00%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
40.9K
Value
$275.2K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	Reduced	-57.47%	$5.5M	Nov 14, 2024
Izzy Englander	Sold	-100.00%	$0	Feb 14, 2025
Izzy Englander	New	—	$4.9M	May 15, 2025
Izzy Englander	Sold	-100.00%	$0	Aug 14, 2025
Izzy Englander	Increased	118.01%	$1.9M	Feb 17, 2026
Izzy Englander	Increased	57.02%	$3.7M	May 15, 2026
Izzy Englander	Reduced	-29.58%	$2.3M	Aug 14, 2026
Cathie Wood	Increased	7.69%	$64.6M	Jan 17, 2024
Cathie Wood	Reduced	-17.48%	$57.1M	Apr 18, 2024
Cathie Wood	Increased	16.29%	$47.8M	Jul 26, 2024
Cathie Wood	Increased	6.92%	$48.8M	Oct 31, 2024
Cathie Wood	Reduced	-7.96%	$32.8M	Feb 4, 2025
Cathie Wood	Increased	3.86%	$21.3M	May 7, 2025
Cathie Wood	Reduced	-14.61%	$22.3M	Jul 30, 2025
Cathie Wood	Increased	39.43%	$16M	Feb 11, 2026
Cathie Wood	Increased	6.07%	$21.4M	May 12, 2026
Cathie Wood	Increased	4.77%	$19.5M	Aug 14, 2026
Ken Griffin	Increased	60.44%	$2.9M	Nov 14, 2024
Ken Griffin	Reduced	-11.70%	$858.2K	May 15, 2025
Ken Griffin	Increased	62.85%	$1.7M	Aug 14, 2025
Ken Griffin	Sold	-100.00%	$0	Nov 14, 2025
Ken Griffin	Reduced	-73.09%	$275.2K	Aug 14, 2026
Steve Cohen	Sold	-100.00%	$0	Nov 14, 2024
Steve Cohen	New	—	$109.3K	Jul 21, 2025
Steve Cohen	Reduced	-40.35%	$80.1K	Aug 14, 2025
Steve Cohen	Sold	-100.00%	$0	Nov 14, 2025
Steve Cohen	New	—	$1.4M	Feb 17, 2026
Steve Cohen	Reduced	-71.26%	$492.9K	May 15, 2026
Steve Cohen	Increased	262.73%	$1.6M	Aug 14, 2026
Cathie Wood	New	—	$48.6M	Oct 18, 2023
Steve Cohen	New	—	$5.9M	Sep 16, 2024
Ken Griffin	New	—	$1.9M	Aug 14, 2024
Izzy Englander	New	—	$5.4M	May 15, 2024

Izzy Englander
Reduced
$5.5M(-57.47%)Nov 14, 2024
Izzy Englander
Sold
$0(-100.00%)Feb 14, 2025
Izzy Englander
New
$4.9MMay 15, 2025
Izzy Englander
Sold
$0(-100.00%)Aug 14, 2025
Izzy Englander
Increased
$1.9M(118.01%)Feb 17, 2026
Izzy Englander
Increased
$3.7M(57.02%)May 15, 2026
Izzy Englander
Reduced
$2.3M(-29.58%)Aug 14, 2026
Cathie Wood
Increased
$64.6M(7.69%)Jan 17, 2024
Cathie Wood
Reduced
$57.1M(-17.48%)Apr 18, 2024
Cathie Wood
Increased
$47.8M(16.29%)Jul 26, 2024
Cathie Wood
Increased
$48.8M(6.92%)Oct 31, 2024
Cathie Wood
Reduced
$32.8M(-7.96%)Feb 4, 2025
Cathie Wood
Increased
$21.3M(3.86%)May 7, 2025
Cathie Wood
Reduced
$22.3M(-14.61%)Jul 30, 2025
Cathie Wood
Increased
$16M(39.43%)Feb 11, 2026
Cathie Wood
Increased
$21.4M(6.07%)May 12, 2026
Cathie Wood
Increased
$19.5M(4.77%)Aug 14, 2026
Ken Griffin
Increased
$2.9M(60.44%)Nov 14, 2024
Ken Griffin
Reduced
$858.2K(-11.70%)May 15, 2025
Ken Griffin
Increased
$1.7M(62.85%)Aug 14, 2025
Ken Griffin
Sold
$0(-100.00%)Nov 14, 2025
Ken Griffin
Reduced
$275.2K(-73.09%)Aug 14, 2026
Steve Cohen
Sold
$0(-100.00%)Nov 14, 2024
Steve Cohen
New
$109.3KJul 21, 2025
Steve Cohen
Reduced
$80.1K(-40.35%)Aug 14, 2025
Steve Cohen
Sold
$0(-100.00%)Nov 14, 2025
Steve Cohen
New
$1.4MFeb 17, 2026
Steve Cohen
Reduced
$492.9K(-71.26%)May 15, 2026
Steve Cohen
Increased
$1.6M(262.73%)Aug 14, 2026
Cathie Wood
New
$48.6MOct 18, 2023
Steve Cohen
New
$5.9MSep 16, 2024
Ken Griffin
New
$1.9MAug 14, 2024
Izzy Englander
New
$5.4MMay 15, 2024

Frequently asked questions

How many institutional investors hold ARCT?: 4 tracked institutional investors disclosed a position in ARCT (ARCTURUS THERAPEUTICS HOLDINGS) in their most recent 13F filing.
Who is the largest institutional holder of ARCT?: Cathie Wood, ARK Investment Management, holds the largest disclosed position in ARCT, valued at $65M.
Did institutional ownership of ARCT increase or decrease?: Across recent 13F filings, tracked investors recorded 7 new positions, 12 increased, 9 reduced, and 5 fully exited ARCT.
Where does this ARCT ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.